Molecular mechanisms leading to null-protein product from retinoschisin (RS1) signal-sequence mutants in X-linked retinoschisis (XLRS) disease.
Retinoschisin (RS1) is a cell-surface adhesion molecule expressed by photoreceptor and bipolar cells of the retina. The 24-kDa protein encodes two conserved sequence motifs: the initial signal sequence targets the protein for secretion while the larger discoidin domain is implicated in cell adhesion. RS1 helps to maintain the structural organization of the retinal cell layers and promotes visual signal transduction. RS1 gene mutations cause X-linked retinoschisis disease (XLRS) in males, characterized by early-onset central vision loss. We analyzed the biochemical consequences of several RS1 signal-sequence mutants (c.1A>T, c.35T>A, c.38T>C, and c.52G>A) found in our subjects. Expression analysis in COS-7 cells demonstrates that these mutations affect RS1 biosynthesis and result in an RS1 null phenotype by several different mechanisms. By comparison, discoidin-domain mutations generally lead to nonfunctional conformational variants that remain trapped inside the cell. XLRS disease has a broad heterogeneity in general, but subjects with the RS1 null-protein signal-sequence mutations are on the more severe end of the clinical phenotype. Results from the signal-sequence mutants are discussed in the context of the discoidin-domain mutations, clinical phenotypes, genotype-phenotype correlations, and implications for RS1 gene replacement therapy.
Vijayasarathy
Camasamudram
C
Section on Translational Research for Retinal and Macular Degeneration, National Institute on Deafness and Other Communication Disorders, National Institutes of Health (NIH), Bethesda, Maryland 20892, USA.
Sui
Ruifang
R
Zeng
Yong
Y
Yang
Guoxing
G
Xu
Fei
F
Caruso
Rafael C
RC
Lewis
Richard A
RA
Ziccardi
Lucia
L
Sieving
Paul A
PA
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D001483:Base Sequence; D019556:COS Cells; D002522:Chlorocebus aethiops; D018387:Codon, Initiator / Q000235:genetics; D004596:Electroretinography; D005091:Exons; D005136:Eye Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D056726:Genetic Association Studies; D015316:Genetic Therapy; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D066298:In Vitro Techniques; D007438:Introns; D008297:Male; D008969:Molecular Sequence Data; D017354:Point Mutation; D017510:Protein Folding; D021382:Protein Sorting Signals / Q000235:genetics; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D041441:Retinoschisis / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy
D018387:Codon, Initiator; D005136:Eye Proteins; D021382:Protein Sorting Signals; C108726:RS1 protein, human; D011994:Recombinant Proteins
J Biol Chem. 1992 Apr 15;267(11):7834-8
1560016
Doc Ophthalmol. 1999;98(2):153-73
10947001
Gene. 2005 Nov 21;361:13-37
16213112
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):991-1000
17325137
Ophthalmic Genet. 1999 Mar;20(1):37-43
10415464
J Biol Chem. 2007 Nov 9;282(45):32792-801
17804407
J Biol Chem. 1990 May 5;265(13):7324-30
2139660
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5375-83
19474399
Mol Cell Biol. 1998 Sep;18(9):5140-7
9710598
Nature. 2003 Dec 18;426(6968):895-9
14685250
Gene Ther. 2009 Jul;16(7):916-26
19458650
Vision Res. 2001 Dec;41(28):3931-42
11738458
J Biol Chem. 2003 Jul 25;278(30):28139-46
12746437
J Lipid Res. 1998 Mar;39(3):509-17
9548584
Br J Ophthalmol. 2009 Mar;93(3):373-8
19019942
Nucleic Acids Res. 1987 Sep 11;15(17):7155-74
3658675
Retina. 2006 Sep;26(7 Suppl):S61-4
16946682
Traffic. 2008 Jun;9(6):861-70
18315532
Genes Dev. 1997 Sep 15;11(18):2396-413
9308967
J Biol Chem. 2005 Mar 18;280(11):10721-30
15644328
Mol Ther. 2008 Jun;16(6):1010-7
18388913
Hum Mol Genet. 2002 Nov 15;11(24):3097-105
12417531
Doc Ophthalmol. 2004 Mar;108(2):135-45
15455796
Graefes Arch Clin Exp Ophthalmol. 2004 Jul;242(7):561-5
14986011
Mol Vis. 2007 Jun 07;13:804-12
17615541
Annu Rev Biochem. 1996;65:367-409
8811184
Vis Neurosci. 2006 Nov-Dec;23(6):887-98
17266781
J Biol Chem. 1991 Oct 25;266(30):19867-70
1939050
Cell. 1988 Aug 26;54(5):621-32
3136928
Exp Eye Res. 2007 Feb;84(2):227-8
16600216
Mol Vis. 2006 Sep 28;12:1108-16
17093404
Hum Mutat. 1999;14(5):423-7
10533068
Br J Ophthalmol. 2006 Jan;90(1):81-6
16361673
Arch Ophthalmol. 2000 Aug;118(8):1098-104
10922205
Can J Ophthalmol. 1998 Apr;33(3):149-58
9606571
Arch Ophthalmol. 1996 Mar;114(3):274-80
8600886
Mol Cell. 2006 Jul 21;23(2):183-93
16857585
Biochem J. 2009 Dec 14;425(1):275-83
19849666
PLoS Biol. 2004 Nov;2(11):e366
15510226
Doc Ophthalmol. 2008 Mar;116(2):97-109
17987333
Retina. 2006 Oct;26(8):940-6
17031297
J Mol Biol. 1987 Aug 20;196(4):947-50
3681984
J Med Genet. 2007 Apr;44(4):225-32
17172462
Hum Mutat. 1999;13(4):338
10220153
Brain Dev. 2006 Jun;28(5):322-5
16376512
Biochem Biophys Res Commun. 2006 Oct 13;349(1):99-105
16930543
Gene. 1999 Jul 8;234(2):187-208
10395892
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5235-42
18599565
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3677-86
18660429
J Biol Chem. 2009 Feb 6;284(6):3966-75
19074145
Genes Dev. 2003 Feb 15;17(4):419-37
12600935
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3837-45
17652759
Acta Ophthalmol Scand. 2004 Apr;82(2):218-23
15043546
Trans Am Ophthalmol Soc. 1999;97:451-64; discussion 464-9
10703138
Mol Vis. 2008;14:2321-32
19093009
Mamm Genome. 2002 Aug;13(8):401-10
12226704
Hum Mol Genet. 2010 Apr 1;19(7):1302-13
20061330
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2491-7
17525175
Surv Ophthalmol. 2004 Mar-Apr;49(2):214-30
14998693
Ophthalmic Genet. 2000 Sep;21(3):171-80
11035549
Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3279-85
15326152
Nat Genet. 1997 Oct;17(2):164-70
9326935